These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27032748)

  • 21. A Synthetic Aptamer-Drug Adduct for Targeted Liver Cancer Therapy.
    Trinh TL; Zhu G; Xiao X; Puszyk W; Sefah K; Wu Q; Tan W; Liu C
    PLoS One; 2015; 10(11):e0136673. PubMed ID: 26523833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells.
    Soundararajan S; Chen W; Spicer EK; Courtenay-Luck N; Fernandes DJ
    Cancer Res; 2008 Apr; 68(7):2358-65. PubMed ID: 18381443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modified AS1411 Aptamer Suppresses Hepatocellular Carcinoma by Up-Regulating Galectin-14.
    Cho Y; Lee YB; Lee JH; Lee DH; Cho EJ; Yu SJ; Kim YJ; Kim JI; Im JH; Lee JH; Oh EJ; Yoon JH
    PLoS One; 2016; 11(8):e0160822. PubMed ID: 27494117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AS1411 derivatives as carriers of G-quadruplex ligands for cervical cancer cells.
    Figueiredo J; Lopes-Nunes J; Carvalho J; Antunes F; Ribeiro M; Campello MPC; Paulo A; Paiva A; Salgado GF; Queiroz JA; Mergny JL; Cruz C
    Int J Pharm; 2019 Sep; 568():118511. PubMed ID: 31301466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-HIV-1 activity of the G-quadruplex ligand BRACO-19.
    Perrone R; Butovskaya E; Daelemans D; Palù G; Pannecouque C; Richter SN
    J Antimicrob Chemother; 2014 Dec; 69(12):3248-58. PubMed ID: 25103489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multifunctional AS1411-functionalized fluorescent gold nanoparticles for targeted cancer cell imaging and efficient photodynamic therapy.
    Ai J; Xu Y; Lou B; Li D; Wang E
    Talanta; 2014 Jan; 118():54-60. PubMed ID: 24274270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toward G-Quadruplex-Based Anticancer Agents: Biophysical and Biological Studies of Novel AS1411 Derivatives.
    Ogloblina AM; Iaccarino N; Capasso D; Di Gaetano S; Garzarella EU; Dolinnaya NG; Yakubovskaya MG; Pagano B; Amato J; Randazzo A
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delivery, Effect on Cell Viability, and Plasticity of Modified Aptamer Constructs.
    Gissberg O; Zaghloul EM; Lundin KE; Nguyen CH; Landras-Guetta C; Wengel J; Zain R; Smith CI
    Nucleic Acid Ther; 2016 Jun; 26(3):183-9. PubMed ID: 26859550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioactivity of 2'-deoxyinosine-incorporated aptamer AS1411.
    Fan X; Sun L; Wu Y; Zhang L; Yang Z
    Sci Rep; 2016 May; 6():25799. PubMed ID: 27194215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Properties of quadruplex oligonucleotides with anti-HIV-1 activity.
    Tamura Y; Yoshida M; Suzuki J; Hiratou T; Miyano-Kurosaki N; Takai K; Takaku H
    Nucleic Acids Symp Ser; 2000; (44):181-2. PubMed ID: 12903328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140.
    Trkola A; Ketas TJ; Nagashima KA; Zhao L; Cilliers T; Morris L; Moore JP; Maddon PJ; Olson WC
    J Virol; 2001 Jan; 75(2):579-88. PubMed ID: 11134270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the conformational behaviour and aggregation properties of lipid-conjugated AS1411 aptamers.
    Riccardi C; Musumeci D; Russo Krauss I; Piccolo M; Irace C; Paduano L; Montesarchio D
    Int J Biol Macromol; 2018 Oct; 118(Pt B):1384-1399. PubMed ID: 30170359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.
    Garvey EP; Johns BA; Gartland MJ; Foster SA; Miller WH; Ferris RG; Hazen RJ; Underwood MR; Boros EE; Thompson JB; Weatherhead JG; Koble CS; Allen SH; Schaller LT; Sherrill RG; Yoshinaga T; Kobayashi M; Wakasa-Morimoto C; Miki S; Nakahara K; Noshi T; Sato A; Fujiwara T
    Antimicrob Agents Chemother; 2008 Mar; 52(3):901-8. PubMed ID: 18160521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted delivery of melittin to cancer cells by AS1411 anti-nucleolin aptamer.
    Rajabnejad SH; Mokhtarzadeh A; Abnous K; Taghdisi SM; Ramezani M; Razavi BM
    Drug Dev Ind Pharm; 2018 Jun; 44(6):982-987. PubMed ID: 29325460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer.
    Bates PJ; Laber DA; Miller DM; Thomas SD; Trent JO
    Exp Mol Pathol; 2009 Jun; 86(3):151-64. PubMed ID: 19454272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AS1411-conjugated gold nanospheres and their potential for breast cancer therapy.
    Malik MT; O'Toole MG; Casson LK; Thomas SD; Bardi GT; Reyes-Reyes EM; Ng CK; Kang KA; Bates PJ
    Oncotarget; 2015 Sep; 6(26):22270-81. PubMed ID: 26045302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biologically active oligodeoxyribonucleotides. 5. 5'-End-substituted d(TGGGAG) possesses anti-human immunodeficiency virus type 1 activity by forming a G-quadruplex structure.
    Hotoda H; Koizumi M; Koga R; Kaneko M; Momota K; Ohmine T; Furukawa H; Agatsuma T; Nishigaki T; Sone J; Tsutsumi S; Kosaka T; Abe K; Kimura S; Shimada K
    J Med Chem; 1998 Sep; 41(19):3655-63. PubMed ID: 9733490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
    Mosafer J; Mokhtarzadeh A
    Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The chemotherapeutic agent bleomycin in a two-drug combination with zidovudine, ritonavir or indinavir synergistically inhibits HIV Type-1 replication in peripheral blood lymphocytes.
    Georgiou NA; van der Bruggen T; Jansen CA; Oudshoorn M; Nottet HS; Marx JJ; van Asbeck BS
    Int J Antimicrob Agents; 2001 Dec; 18(6):513-8. PubMed ID: 11738337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aptamer imaging with Cu-64 labeled AS1411: preliminary assessment in lung cancer.
    Li J; Zheng H; Bates PJ; Malik T; Li XF; Trent JO; Ng CK
    Nucl Med Biol; 2014 Feb; 41(2):179-85. PubMed ID: 24373858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.